HP
Hitesh Popatlal Oswal
About Hitesh Popatlal Oswal
Data last updated:
Hitesh Popatlal Oswal is a Director at Preet Remedies Limited (since 2020), Director at Shubh Medicorp (India) Private Limited (since 2013) and Director at Quixotic Pharma Private Limited (since 2018). The companies operate in Pharma, Financial Services and Consumer Goods. The 3 current companies with reported revenue have a combined latest revenue of ₹123 Cr; the largest is Preet Remedies Limited at ₹62.83 Cr (FY 2025). Earlier, Hitesh Popatlal Oswal was a Partner at Mantra Generics And Surgical Llp (2023–2024) and Additional Director at Zenlabs Ethica Limited (2022–2023) and 2 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Preet Remedies Limited U24230CH2005PLC027954 | Director | 25 Sep 2020 | 2005 | ₹62.83 Cr (FY 2025) | Active |
 Shubh Medicorp (India) Private Limited U74999PN2013PTC149470 | Director | 19 Nov 2013 | 2013 | ₹32.12 Cr (FY 2024) | Active |
 Quixotic Pharma Private Limited U24232PB2002PTC025609 | Director | 01 Feb 2018 | 2002 | ₹27.58 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Mantra Generics And Surgical Llp ACB-5516 | Partner | 09 Jun 2023 | 2023 | Active | |
 Zenlabs Ethica Limited L74900CH1993PLC033112 | Additional Director | 21 Nov 2022 | 1993 | ₹51.47 Cr (FY 2025) | Active |
 Regalia Pharmaceutical (India) Private Limited U24232PN2007PTC130885 | Director | 01 Jun 2017 | 2007 | ₹98.6 Lakh (FY 2024) | Active |
| Garron Labs Private Limited U51909PN2013PTC147604 | Director | 05 Jan 2015 | 2013 | ₹85.6 Lakh (FY 2020) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Hitesh Popatlal Oswal
| Name | DIN | Company | Designation |
|---|---|---|---|
| Abhishek Rana | 10480804 | Preet Remedies Limited | Director |
| Prasanna Kumar Rout | 10432013 | Preet Remedies Limited | Director |
| Sanjay Dhir | 02452461 | Preet Remedies Limited , Quixotic Pharma Private Limited | Director |
| Sanjeev Kumar | 01154896 | Preet Remedies Limited , Quixotic Pharma Private Limited | Managing Director |
| Vijendra Kumar Gupta | 10944835 | Preet Remedies Limited | Director |
| Amit Popatlal Oswal | 06716020 | Shubh Medicorp (India) Private Limited | Director |
| Rajesh Popatlal Oswal | 06473577 | Shubh Medicorp (India) Private Limited | Director |
| Sudhakar | 10278181 | Quixotic Pharma Private Limited | Director |
| Ashok Kumar Mishra | 10982749 | Quixotic Pharma Private Limited | Director |
| Rajesh Biswanath Shrivastava | 00155198 | Quixotic Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Hitesh Popatlal Oswal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Hitesh Popatlal Oswal
Hitesh Popatlal Oswal currently holds 3 directorships: Preet Remedies Limited (Director, since 25 Sep 2020, revenue ₹62.83 Cr (FY 2025)); Shubh Medicorp (India) Private Limited (Director, since 19 Nov 2013, revenue ₹32.12 Cr (FY 2024)); Quixotic Pharma Private Limited (Director, since 01 Feb 2018, revenue ₹27.58 Cr (FY 2025)).
Hitesh Popatlal Oswal was first appointed on 19 Nov 2013 as Director at Shubh Medicorp (India) Private Limited. The most recent appointment on record is 09 Jun 2023 at Mantra Generics And Surgical Llp.
The 3 current companies of Hitesh Popatlal Oswal that report revenue have a combined latest revenue of ₹123 Cr: Preet Remedies Limited ₹62.83 Cr (FY 2025); Shubh Medicorp (India) Private Limited ₹32.12 Cr (FY 2024); Quixotic Pharma Private Limited ₹27.58 Cr (FY 2025).
Hitesh Popatlal Oswal held 4 earlier board appointments: Mantra Generics And Surgical Llp (Partner, 09 Jun 2023 to 17 Feb 2024); Zenlabs Ethica Limited (Additional Director, 21 Nov 2022 to 30 Sep 2023); Regalia Pharmaceutical (India) Private Limited (Director, 01 Jun 2017 to 31 Mar 2023); Garron Labs Private Limited (Director, 05 Jan 2015 to 26 Nov 2020).
The current boards of Hitesh Popatlal Oswal's companies include Abhishek Rana (Preet Remedies Limited), Prasanna Kumar Rout (Preet Remedies Limited), Sanjay Dhir (Preet Remedies Limited), Sanjeev Kumar (Preet Remedies Limited), Vijendra Kumar Gupta (Preet Remedies Limited), Amit Popatlal Oswal (Shubh Medicorp (India) Private Limited), among others.